HD-OPM Archive
Topics › Blood pressure, salt & potassium

ARBs, thiazides and DHP calcium blockers tied to fewer dementia markers than ACE drugs

Louis Nervegna · Feb 18, 2026 · ♥ 9 reactions · 3 comments · original Facebook post
Blood pressure, salt & potassiumBrain health & dementia
AI summary & key facts

An autopsy cohort found blood pressure drugs that stimulate angiotensin II signaling were linked to lower Alzheimer's biomarkers and less brain small-vessel disease than those that inhibit it.

Medications that stimulate angiotensin II (ARB’s, thiazides, dihydropyridine calcium channel blockers) may be the best blood pressure drugs for reducing risk of dementia.

This is in comparison to blood pressure medications that inhibit angiotensin II (ACE inhibitors, beta blockers, non-dihydropyridine calcium channel blockers).

Link to full journal paper:

Paper · JAMA Network OpenJAMA Network Open articlejamanetwork.com

#arbsHD #bloodpressureHD #dementiaHD #alzheimersHD #thiazidesHD #calciumchannelblockersHD #angiotensinHD

Research cited

Shared from Medscape · original post

Some antihypertensive drugs are better than others for reducing the risk of developing biomarkers of dementia, according to new research published in JAMA Network Open.

The autopsy cohort study found that angiotensin II receptor stimulating drugs were associated with lower levels of a biomarker for Alzheimer’s disease in several brain regions than drugs that inhibit angiotensin II. The risk reductions ranged from 14% to 21%.

Most notably, use of these drugs for 15 years or more was associated with a 24% lower risk for arteriolosclerosis. Angiotensin II is a hormone responsible for controlling blood pressure by constricting blood vessels. Not All Blood Pressure Drugs Equal for Dementia (Medscape)

No photo description available.
← newer: IARC classifies processed meat as a Group 1 carcinogen, likeolder: Nitrates are beneficial, nitrosamines are carcinogenic: why →